SURMOUNT-4
SURMOUNT-4

Type of Study:
Double-blind, placebo controlled trial for weight maintenance or weight loss for participants who have obesity or are overweight with weight- related diseases.

Study Length:
about 2 years

Target Age/Sex:
over 18 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: On Hold

Description:

This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo.

This Study is On Hold.